Hjem › Multipelt myelom › Michigan › Grand Rapids
Multipelt myelom kliniske forsøg i Grand Rapids, MI
8 studier for Multipelt myelom søger deltagere på steder i og omkring Grand Rapids (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
RekruttererFase 1
- START Midwest /ID# 279035, Grand Rapids
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekruttererFase 3
- Cancer And Hematology Centers of Western Michigan PC, Grand Rapids
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruttererFase 2
- Cancer Research Consortium of West Michigan, Grand Rapids
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RekruttererFase 1/2
- GSK Investigational Site, Grand Rapids
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
RekruttererFase 1
- START Midwest, Grand Rapids
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
RekruttererFase 2
- START Midwest, Grand Rapids
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RekruttererFase 3
- Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids
- Spectrum Health at Butterworth Campus, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
RekruttererFase 1
- START Midwest, Grand Rapids
Multipelt myelom forsøg i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Grand Rapids
- Ikke-småcellet lungecancer44 studier
- Colorektal kræft40 studier
- Kræft (alle typer)28 studier
- Brystkræft25 studier
- Ægstockræft24 studier
- Metastatisk cancer22 studier
- Prostatakræft19 studier
- Livmoderslimhindekræft18 studier
- Mavekræft18 studier
- Bugspytkirtelkræft18 studier
- Melanom17 studier
- Tripelnegativ brystkræft15 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.